After years of criticism from the FDA, Sun’s Halol plant still can’t get through an FDA inspection without the agency finding some deficiency. In June, it was just one observation, but a just ...

India’s Sun Pharmaceuticals, which is working hard to shift its focus from generic to novel and specialty drugs, has won FDA approval of a new treatment for glaucoma. The drug will be made at Sun’s ...

Add Yahoo as a preferred source to see more of our stories on Google. A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai May ...

MUMBAI – The U.S. Food and Drug Administration (FDA) has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report ...

MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd has been warned by U.S. health regulators for violating manufacturing standards at its Halol plant in India, even as it ...

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, ...

Sun Pharma shares fell almost 7% in the early trading session on Monday after the pharma major's Halol facility was classified an OAI (Official Action Initiated) by USFDA. Sun Pharma received a letter ...

A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations. In the letter to Mumbai-based company, the USFDA pointed out drug firm's ...

The US Food and Drug Administration (FDA) had listed Sun Pharmaceutical Industries Ltd's Halol facility in Gujarat under an import alert, the company said today. Shares of Sun Pharmaceutical ...

India's leading pharmaceutical company Sun Pharma's manufacturing quality issues at its troubled Halol plant in Gujarat are continuing and may require at least three-four months to resolve. The US ...